Literature DB >> 12832441

Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells.

Niclas Setterblad1, Corinne Roucard, Claire Bocaccio, Jean-Pierre Abastado, Dominique Charron, Nuala Mooney.   

Abstract

Dendritic cells (DCs) are the most potent antigen presenting cells. Major histocompatibility complex (MHC) class II molecule expression changes with maturation; immature DCs concentrate MHC class II molecules intracellularly, whereas maturation increases surface expression of MHC class II and costimulatory molecules to optimize antigen presentation. Signal transduction via MHC class II molecules localized in lipid microdomains has been described in B lymphocytes and in the THP-1 monocyte cell line. We have characterized MHC class II molecules throughout human DC maturation with particular attention to their localization in lipid-rich microdomains. Only immature DCs expressed empty MHC class II molecules, and maturation increased the level of peptide-bound heterodimers. Ligand binding to surface human leukocyte antigen (HLA)-DR induced rapid internalization in immature DCs. The proportion of cell-surface detergent-insoluble glycosphingolipid-enriched microdomain-clustered HLA-DR was higher in immature DCs despite the higher surface expression of HLA-DR in mature DCs. Constituents of HLA-DR containing microdomains included the src kinase Lyn and the cytoskeletal protein tubulin in immature DCs. Maturation modified the composition of the HLA-DR-containing microdomains to include protein kinase C (PKC)-delta, Lyn, and the cytoskeletal protein actin, accompanied by the loss of tubulin. Signaling via HLA-DR redistributed HLA-DR and -DM and PKC-delta as well as enriching the actin content of mature DC microdomains. The increased expression of HLA-DR as a result of DC maturation was therefore accompanied by modification of the spatial organization of HLA-DR. Such regulation could contribute to the distinct responses induced by ligand binding to MHC class II molecules in immature versus mature DCs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832441     DOI: 10.1189/jlb.0103045

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

Review 1.  A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules.

Authors:  Zoltan A Nagy; Nuala A Mooney
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

2.  Distinct MHC class II molecules are associated on the dendritic cell surface in cholesterol-dependent membrane microdomains.

Authors:  Sanjay Khandelwal; Paul A Roche
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

3.  MHC Class II and CD9 in human eosinophils localize to detergent-resistant membrane microdomains.

Authors:  Praveen Akuthota; Rossana C N Melo; Lisa A Spencer; Peter F Weller
Journal:  Am J Respir Cell Mol Biol       Date:  2011-09-01       Impact factor: 6.914

Review 4.  MHC class II association with lipid rafts on the antigen presenting cell surface.

Authors:  Howard A Anderson; Paul A Roche
Journal:  Biochim Biophys Acta       Date:  2014-09-28

5.  RAFTsomes containing epitope-MHC-II complexes mediated CD4+ T cell activation and antigen-specific immune responses.

Authors:  Qian Ding; Jian Chen; Xiaohui Wei; Wenqiang Sun; Junhua Mai; Yanzhu Yang; Yuhong Xu
Journal:  Pharm Res       Date:  2012-08-10       Impact factor: 4.200

6.  The tetraspanin CD9 mediates lateral association of MHC class II molecules on the dendritic cell surface.

Authors:  Julia J Unternaehrer; Amy Chow; Marc Pypaert; Kayo Inaba; Ira Mellman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 11.205

Review 7.  High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.

Authors:  S-H Wang; S-G Yuan; D-Q Peng; S-P Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-06       Impact factor: 4.330

8.  High-density lipoproteins and the immune system.

Authors:  Hidesuke Kaji
Journal:  J Lipids       Date:  2013-01-30

9.  High density lipoproteins and atherosclerosis: emerging aspects.

Authors:  Federica Sala; Alberico Luigi Catapano; Giuseppe Danilo Norata
Journal:  J Geriatr Cardiol       Date:  2012-12       Impact factor: 3.327

Review 10.  Organizing MHC Class II Presentation.

Authors:  David R Fooksman
Journal:  Front Immunol       Date:  2014-04-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.